Scyllo-Inositol Pharmaceutical Grade from China
Scyllo-inositol is an inositol stereoisomer researched for Alzheimer's treatment, classified under HTS 2906.13.10.00 as a pure cyclic alcohol. It meets pharmacopeia standards for use in clinical trials and drug development.
Duty Rate — China → United States
35%
Rate breakdown
9903.03.0110%Except for products described in headings 9903.03.02–9903.03.11, articles the product of any country, as provided for in subdivision (aa) of U.S. note 2 to this subchapter
9903.88.0325%Except as provided in headings 9903.88.13, 9903.88.18, 9903.88.33, 9903.88.34, 9903.88.35, 9903.88.36, 9903.88.37, 9903.88.38, 9903.88.40, 9903.88.41, 9903.88.43, 9903.88.45, 9903.88.46, 9903.88.48, 9903.88.56, 9903.88.64, 9903.88.66, 9903.88.67, 9903.88.68, or 9903.88.69, articles the product of China, as provided for in U.S. note 20(e) to this subchapter and as provided for in the subheadings enumerated in U.S. note 20(f)
Import Tips
• Include USP/EP certificate of analysis proving ≥98% purity to maintain Chapter 29 classification
• Declare intended use as bulk API; finished dosage forms reclassify to Chapter 30
• Monitor for DEA scheduling if combined with other actives, though pure inositols are unregulated